Cargando…

Correction to: Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy

Detalles Bibliográficos
Autores principales:	Ryckman, Jeffrey M., Baine, Michael, Carmicheal, Joseph, Osayande, Ferdinand, Sleightholm, Richard, Samson, Kaeli, Zheng, Dandan, Zhen, Weining, Lin, Chi, Zhang, Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028196/ https://www.ncbi.nlm.nih.gov/pubmed/33827622 http://dx.doi.org/10.1186/s13014-021-01797-3

Ejemplares similares

Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2020)

Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer
por: Kita, Nozomi, et al.
Publicado: (2023)

Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer
por: Nakamura, Masaki, et al.
Publicado: (2016)

Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2017)

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
por: McLaughlin, Mark F., et al.
Publicado: (2020)

Radiation therapy for pineal parenchymal tumor of intermediate differentiation: A case series and literature review
por: Liu, Cassie, et al.
Publicado: (2023)

Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Multiple Pulmonary Oligometastases or Synchronous Primary Lung Cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy
por: Parr, Elsa, et al.
Publicado: (2020)

Dosimetric comparison between stereotactic body radiotherapy and carbon-ion radiation therapy for prostate cancer
por: Huang, He-Fa, et al.
Publicado: (2023)

The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?
por: Ryckman, Jeffrey M., et al.
Publicado: (2021)

The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung
por: Ochiai, Satoru, et al.
Publicado: (2016)

3D deep convolution neural network for radiation pneumonitis prediction following stereotactic body radiotherapy
por: Kapoor, Rishabh, et al.
Publicado: (2022)

Assessment of biological dosimetric margin for stereotactic body radiation therapy
por: Kawahara, Daisuke, et al.
Publicado: (2020)

Radiation Therapy Improves Local Control in Juvenile Nasopharyngeal Angiofibroma following Disease Progression after Embolization and Surgical Resection: A Case Report
por: Blank, Zane, et al.
Publicado: (2021)

Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors
por: Yamashita, Hideomi, et al.
Publicado: (2007)

New Clinical Features and Dosimetric Predictor Identification for Symptomatic Radiation Pneumonitis after Tangential Irradiation in Breast Cancer Patients
por: Wen, Ge, et al.
Publicado: (2017)

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
por: Hsu, Shih-Ming, et al.
Publicado: (2017)

The dosimetric impact of implants on the spinal cord dose during stereotactic body radiotherapy
por: Yazici, Gozde, et al.
Publicado: (2016)

Comparison of four techniques for spine stereotactic body radiotherapy: Dosimetric and efficiency analysis
por: Aljabab, Saif, et al.
Publicado: (2018)

Evaluating risk factors of radiation pneumonitis after stereotactic body radiation therapy in lung tumor: Meta-analysis of 9 observational studies
por: Lu, Chi, et al.
Publicado: (2018)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy
por: Ye, Luxi, et al.
Publicado: (2019)

Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma
por: Abe, Takanori, et al.
Publicado: (2015)

A 47-year-old woman with nuclear protein in testis midline carcinoma masquerading as a sinus infection: a case report and review of the literature
por: Elkhatib, Safwan K., et al.
Publicado: (2019)

Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer
por: Seppälä, Jan, et al.
Publicado: (2016)

Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
por: Eckl, Miriam, et al.
Publicado: (2021)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022)

Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison
por: Dahbi, Zineb, et al.
Publicado: (2023)

Quantification of renal function following stereotactic body radiotherapy for pancreatic cancer: secondary dosimetric analysis of a prospective clinical trial
por: Verma, Vivek, et al.
Publicado: (2017)

Dosimetric comparison of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and helical tomotherapy for lung stereotactic body radiotherapy
por: Kinhikar, Rajesh Ashok, et al.
Publicado: (2015)

Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer
por: Wu, Guangyin, et al.
Publicado: (2019)

Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy
por: Yang, Liu-Ting, et al.
Publicado: (2021)

Target migration from re-inflation of adjacent atelectasis during lung stereotactic body radiotherapy
por: Mao, Bijing, et al.
Publicado: (2017)

Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer
por: Jiao, Yuxin, et al.
Publicado: (2020)

Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
por: Kraus, Kim Melanie, et al.
Publicado: (2023)

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy
por: Chapman, Christopher H., et al.
Publicado: (2018)

Pretreatment Factors Influencing Radiation Pneumonitis after Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
por: Harris, Alexander A, et al.
Publicado: (2020)

Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis
por: Inoue, Toshihiko, et al.
Publicado: (2015)

Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy
por: Han, Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ok98ar9c1ck3vp6dta1ncu08n